Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	2,717	2,998	3,699	4,858	3,994	4,317	6,865	6,565	6,347	7,304	8,422
COGS	-1,520	-1,648	2,149	2,893	1,967	2,043	3,248	3,802	3,864	4,701	5,499
Gross profit	—	—	1,550	1,965	2,027	2,273	3,617	2,763	2,483	2,603	2,923
	3,707	4,037	894	1,051	1,098	1,339	1,726	1,675	1,507	1,598	1,761
	530	608	657	914	930	935	1,891	1,088	976	1,005	1,163
OPM %	19.5%	20.3%	17.8%	18.8%	23.3%	21.7%	27.5%	16.6%	15.4%	13.8%	13.8%
Depreciation	93	115	136	160	173	218	281	310	377	433	473
Interest	116	117	131	181	122	86	113	166	211	275	339
	10	3	2	5	11	2	3	0	8	19	14
Profit before tax	331	379	392	578	646	632	1,500	613	396	316	365
Tax	79	72	76	108	123	119	211	67	-21	-24	-57
Tax %	23.8%	19%	19.4%	18.8%	19%	18.8%	14.1%	11%	-5.3%	-7.5%	-15.6%
	252	307	316	469	523	514	1,289	546	417	340	422
PAT margin %	9.3%	10.2%	8.6%	9.7%	13.1%	11.9%	18.8%	8.3%	6.6%	4.7%	5%
EPS (₹)	29.9	37.1	38.9	7.6	30	29.5	35.6	15.1	11.5	9.4	11.7
EPS adjusted (₹)	—	—	—	—	—	14.7	35.6	15.1	11.5	9.4	11.7
	28.5%	2.7%	2.6%	144.2%	11.7%	10.2%	9.8%	16.6%	8.7%	10.7%	8.6%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	87	181	181	181	181	181
Reserves	3,325	5,604	4,740	5,111	5,437	5,791
	2,487	2,202	2,874	3,183	3,788	4,920
	1,615	1,516	795	1,167	1,709	2,268
Total equity & liabilities	7,514	9,504	8,590	9,643	11,115	13,159
	3,511	4,336	4,824	5,605	6,330	6,355
CWIP	1,298	1,490	989	1,059	1,276	2,030
Investments	36	43	12	19	90	189
	2,669	3,634	2,765	2,960	3,420	4,586
Total assets	7,514	9,504	8,590	9,643	11,115	13,159

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2022 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Speciality Chemicals	6,465.03	1,578.71	—	1,032.92
Pharmaceuticals	1,299.93	220.33	—	244.98

SegmentFigure

Pharmaceuticals · revenue

₹ crore by fiscal year

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	844	442	1,272	1,166	1,282	608
	-1,307	-1,296	-1,301	-1,270	-1,435	-1,141
	635	672	55	35	-74	746
Net cash flow	173	-182	27	-69	-227	213
Free cash flow	-464	-857	-32	-119	-100	-516
CFO / Operating profit %	90.3%	23.4%	116.9%	119.5%	127.5%	52.3%